ClinicalTrials.Veeva

Menu

Pediatric Second Influenza Dose Portal Reminder Recall

University of California, Los Angeles (UCLA) logo

University of California, Los Angeles (UCLA)

Status

Completed

Conditions

Influenza
Respiratory Tract Infections

Treatments

Behavioral: Portal Reminders for Second Dose of Influenza Vaccine without Direct Scheduling Link
Behavioral: Portal Reminders for Second Dose of Influenza Vaccine with Direct Scheduling Link

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT04668417
17-001889-AM-00013
5R01AI135029 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

This trial is taking place in Los Angeles, CA among patients from primary care practices within the UCLA Health System.

The study design is a parallel 2-arm trial. The parallel arms are 1) a reminder letter for the second dose of influenza vaccine (reminder messages sent via the patient portal) with a direct appointment scheduling link included in the reminder and 2) a reminder letter for the second dose of influenza vaccine, but no direct appointment scheduling link included.

Full description

This trial is taking place in Los Angeles, CA among patients from primary care practices within the UCLA Health System, using a parallel 2-arm trial.

Sub-optimal vaccination rates are a significant problem in the U.S., despite their effectiveness in preventing morbidity and mortality from vaccine-preventable illness. In the U.S., annual epidemics of influenza cause substantial morbidity in the U.S. with up to 40,00-80,000 deaths/year and many hospitalizations, emergency and outpatient visits, and significant costs.

Young children-especially those younger than 2- are at high risk of developing serious flu-related complications. Children ages of 6 months to 8 years getting vaccinated for the first time with influenza vaccine should get two doses, and those who have only previously gotten one dose of influenza vaccine, should get a second dose (spaced at least 4 weeks apart).

Reminder/recall (R/R) messages, sent by phone, mail or other modality, can improve child vaccination rates. However, the majority of pediatric or adult primary care practices to not conduct R/R. Barriers are lack of finances, personnel, and algorithms to identify eligible patients. A technological breakthrough that might overcome these barriers involves patient portals-- secure, web-based communication systems, embedded within electronic health records (EHRs), for patients and providers to communicate with each other via email and the internet. Portals are increasingly used by healthcare systems.

This randomized controlled trial will assess the effectiveness of reminders messages, sent to the proxy of pediatric patients ages 6 months to <36 months of age eligible for a second dose of the influenza vaccine based on data in the EHR. Patients will be randomized into one of two arms to receive 1) a reminder letter for a second dose of influenza vaccine, with a direct appointment scheduling link included in the letter or 2) a reminder letter for a second dose of influenza vaccine, without a direct appointment scheduling link included in the letter.

Enrollment

698 patients

Sex

All

Ages

6 to 36 months old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patient within the UCLA Health System identified as a primary care patient per an internal algorithm
  • Identified as being overdue for a second dose of influenza vaccine.

Exclusion criteria

  • Patient within the UCLA Health System not identified as a primary care patient per an internal algorithm
  • Not due for a second dose of influenza vaccine.

Trial design

Primary purpose

Health Services Research

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

698 participants in 2 patient groups

Reminders with direct scheduling link
Active Comparator group
Description:
Patient proxy receives a reminder/recall messages regarding second dose influenza vaccination via the patient portal with a link enabling direct scheduling
Treatment:
Behavioral: Portal Reminders for Second Dose of Influenza Vaccine with Direct Scheduling Link
Reminders with no direct scheduling link
Active Comparator group
Description:
Patient proxy receives a reminder/recall messages regarding second dose influenza vaccination via the patient portal with no direct scheduling link
Treatment:
Behavioral: Portal Reminders for Second Dose of Influenza Vaccine without Direct Scheduling Link

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems